Mark D. Moore

1.7k total citations
22 papers, 1.2k citations indexed

About

Mark D. Moore is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Mark D. Moore has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Mark D. Moore's work include Pulmonary Hypertension Research and Treatments (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Peptidase Inhibition and Analysis (4 papers). Mark D. Moore is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Peptidase Inhibition and Analysis (4 papers). Mark D. Moore collaborates with scholars based in United States, Puerto Rico and South Korea. Mark D. Moore's co-authors include Mark W. Geraci, Norbert F. Voelkel, Rubin M. Tuder, Heiko Golpon, Bifeng Gao, Sylk Sotto‐Santiago, Christopher D. Coldren, Robert L. Keith, S. Patrick Nana‐Sinkam and Michael E. Yeager and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mark D. Moore

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Moore United States 14 696 466 212 185 152 22 1.2k
Megha Talati United States 21 1.1k 1.6× 451 1.0× 550 2.6× 170 0.9× 195 1.3× 34 1.6k
Daoming Qiu United States 12 410 0.6× 612 1.3× 235 1.1× 179 1.0× 86 0.6× 12 1.4k
Paola Caruso Italy 14 629 0.9× 690 1.5× 174 0.8× 521 2.8× 99 0.7× 37 1.3k
Eva Dony Germany 11 605 0.9× 275 0.6× 276 1.3× 73 0.4× 296 1.9× 15 990
Jan Willem N. Akkerman Netherlands 18 158 0.2× 254 0.5× 280 1.3× 75 0.4× 110 0.7× 29 1.2k
Fares A. Masri United States 6 596 0.9× 325 0.7× 222 1.0× 147 0.8× 147 1.0× 8 817
Zhen Yao China 13 443 0.6× 451 1.0× 85 0.4× 263 1.4× 70 0.5× 45 1.2k
Susana Carrasco Spain 17 358 0.5× 583 1.3× 60 0.3× 282 1.5× 202 1.3× 27 1.4k
Françoise Goirand France 18 293 0.4× 287 0.6× 130 0.6× 56 0.3× 212 1.4× 44 909

Countries citing papers authored by Mark D. Moore

Since Specialization
Citations

This map shows the geographic impact of Mark D. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Moore more than expected).

Fields of papers citing papers by Mark D. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Moore. The network helps show where Mark D. Moore may publish in the future.

Co-authorship network of co-authors of Mark D. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Moore. A scholar is included among the top collaborators of Mark D. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Moore. Mark D. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bull, Todd M., Christina A. Meadows, Christopher D. Coldren, et al.. (2008). Human Herpesvirus-8 Infection of Primary Pulmonary Microvascular Endothelial Cells. American Journal of Respiratory Cell and Molecular Biology. 39(6). 706–716. 25 indexed citations
2.
Nana‐Sinkam, S. Patrick, Jong Deog Lee, Sylk Sotto‐Santiago, et al.. (2007). Prostacyclin Prevents Pulmonary Endothelial Cell Apoptosis Induced by Cigarette Smoke. American Journal of Respiratory and Critical Care Medicine. 175(7). 676–685. 107 indexed citations
3.
Gruber, Michael P., Christopher D. Coldren, Gregory P. Cosgrove, et al.. (2006). Human Lung Project: Evaluating Variance of Gene Expression in the Human Lung. American Journal of Respiratory Cell and Molecular Biology. 35(1). 65–71. 31 indexed citations
4.
Nana‐Sinkam, Patrick, Ryan Oyer, Robert S. Stearman, et al.. (2005). Prostacyclin Synthase Promoter Regulation and Familial Pulmonary Arterial Hypertension. CHEST Journal. 128(6). 612S–612S. 4 indexed citations
5.
Bull, Todd, Chris D. Coldren, Patrick Nana‐Sinkam, et al.. (2005). Microarray Analysis of Peripheral Blood Cells in Pulmonary Arterial Hypertension, Surrogate to Biopsy. CHEST Journal. 128(6). 584S–584S. 4 indexed citations
6.
Bull, Todd, Christopher D. Coldren, Mark D. Moore, et al.. (2004). Gene Microarray Analysis of Peripheral Blood Cells in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 170(8). 911–919. 120 indexed citations
7.
Nana‐Sinkam, Patrick, Heiko Golpon, Robert L. Keith, et al.. (2004). Prostacyclin in Human Non-small Cell Lung Cancers. CHEST Journal. 125(5). 141S–141S. 13 indexed citations
8.
Golpon, Heiko, Christopher D. Coldren, Martin R. Zamora, et al.. (2004). Emphysema Lung Tissue Gene Expression Profiling. American Journal of Respiratory Cell and Molecular Biology. 31(6). 595–600. 112 indexed citations
9.
Hoshikawa, Yasushi, Patrick Nana‐Sinkam, Mark D. Moore, et al.. (2003). Hypoxia induces different genes in the lungs of rats compared with mice. Physiological Genomics. 12(3). 209–219. 74 indexed citations
10.
Golpon, Heiko, Mark W. Geraci, Mark D. Moore, et al.. (2001). HOX Genes in Human Lung. American Journal Of Pathology. 158(3). 955–966. 85 indexed citations
11.
Geraci, Mark W., Mark D. Moore, Michael E. Yeager, et al.. (2001). Gene Expression Patterns in the Lungs of Patients With Primary Pulmonary Hypertension. Circulation Research. 88(6). 555–562. 220 indexed citations
12.
Geraci, Mark W., Bifeng Gao, David Shepherd, et al.. (1999). Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. Journal of Clinical Investigation. 103(11). 1509–1515. 166 indexed citations
13.
Cook, R.M., Wilbur A. Franklin, Mark D. Moore, Bruce E. Johnson, & York E. Miller. (1998). Mutational inactivation of aminoacylase-1 in a small cell lung cancer cell line. Genes Chromosomes and Cancer. 21(4). 320–325. 9 indexed citations
14.
Cook, R.M., William A. Franklin, Mark D. Moore, Bruce E. Johnson, & Y E Miller. (1998). Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line.. PubMed. 21(4). 320–5. 12 indexed citations
15.
Shepp, David H., C H Ramírez-Ronda, Lawrence Dall, et al.. (1997). A Comparative Trial of Zidovudine Administered Every Four Versus Every Twelve Hours for the Treatment of Advanced HIV Disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(4). 283–288. 6 indexed citations
16.
Geraci, Mark W., et al.. (1997). Rat Prostacyclin Synthase. CHEST Journal. 111(6). 129S–129S. 7 indexed citations
17.
Cohen, Andrea J., et al.. (1996). Inactivation of Neutral Endopeptidase in Lung Cancer. CHEST Journal. 109(3). 12S–13S. 2 indexed citations
18.
Castranova, Vincent, et al.. (1991). Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: Correlation between binding affinity, inhibitory potency, and antifibrotic potential. Toxicology and Applied Pharmacology. 108(2). 242–252. 16 indexed citations
19.
Moore, Mark D., et al.. (1988). Cloning and characterization of the 5-aminolevulinate synthase gene(s) from Rhodobacter sphaeroides. Gene. 70(1). 139–151. 44 indexed citations
20.
McCann, Shaun R., et al.. (1976). IgM pyroglobulinemia with erythrocytosis presenting as hyperviscosity syndrome. The American Journal of Medicine. 61(3). 316–320. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megha Talati Breakdown of academic impact, for papers by Daoming Qiu Breakdown of academic impact, for papers by Paola Caruso Breakdown of academic impact, for papers by Eva Dony Breakdown of academic impact, for papers by Jan Willem N. Akkerman Breakdown of academic impact, for papers by Fares A. Masri Breakdown of academic impact, for papers by Zhen Yao Breakdown of academic impact, for papers by Susana Carrasco Breakdown of academic impact, for papers by Françoise Goirand
Rankless by CCL
2026